AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application
HONG KONG, Feb. 12, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for...
YQN at CES 2025: Redefining Smart Logistics for Global Trade
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- The globally renowned CES, widely recognized as a barometer of consumer electronics and technology trends, recently opened in Las Vegas, USA, attracting technology giants, business leaders, and media from...